Webinars All webinars

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats
Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Tumors of the skin and subcutaneous tissues are the most common malignancies in dogs and cats accounting for over 30-40% of tumors in dogs and 29% in cats. Surgery is typically the first line treatment for most cutaneous and subcutaneous malignancies, and the phrase ‘a chance to cut is a chance to cure’ is certainly accurate with respect to many tumors.
Mast cell tumors and soft tissue sarcomas are the two most common skin malignancies in dogs whereas they are the third and fourth most common skin malignancies in cats (behind squamous cell carcinoma and basal cell tumors). This presentation will focus on mast cell tumors and soft tissue sarcomas in both species (squamous cell carcinomas and basal cell tumors will not be covered). The presentation will cover biologic behaviour of these tumors, considerations for staging and work-up, and treatment options with a focus on surgery, but discussion on adjuvant and alternative treatment methods will also be covered.

Recording from 30 June 2021

Speaker:

Dr-Stephanie-Colthurst-new.jpg

Stephanie Colthurst

Dr Stephanie Colthurst - Surgery BVSc. (James Cook)

Stephanie is a small animal surgeon at Veterinary Specialist Services in Brisbane (Australia). She has worked in referral practice for 9 years. Following graduation from James Cook University in 2014, she completed a 12-month rotating internship at Veterinary Specialist Services followed by a second internship at Southpaws in Melbourne (Australia) in 2016 before enrolling into a surgical residency at Southpaws through the European College of Veterinary Surgeons (ECVS).

Stephanie successfully passed her memberships of the Australian and New Zealand College of Veterinary Scientists in Small Animal Surgery in 2018 and has just successfully passed her ECVS board examinations in February 2023 on her first attempt.

Stephanie returned to Veterinary Specialist Services in 2021. Whilst she enjoys all aspects of surgery, her particular interests are in soft tissue and oncologic surgery. She is passionate about keeping up to date with advances in veterinary research, so that she can strive to provide the best possible care for each patient and their owner.

Booking information

Duration: 0:51 h
Speaker: Stephanie Colthurst
from 1
54.90 US$
(incl. tax)

You might also be interested in

lumbectomies 300x200.png
Barney Dean
1:07 h

Don't Get Stumped by Lumps - Approaching Tricky Lumpectomies 

This webinar will discuss the rationale behind sound investigation and management of tricky mass removals, and how to adapt a plan to suit owner circumstances. 
 
staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient

Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
ICC image small.jpg
Sue Jaensch
0:50 h

Advanced diagnostics in canine and feline lymphoma.

So you have a diagnosis of lymphoma in your small animal patient. What next?  Classification of lymphoma is increasingly important for both prognostic and therapeutic decision making. This webinar will discuss diagnostic options to optimise the diagnostic process in your patient.  Modalities discussed will include immunocytochemistry, immunohistochemistry, flow cytometry and PARR.